Receptor tyrosine kinase-like orphan receptor 1 (ROR1) functions as an oncofetal protein, predominantly expressed during embryonic development where it plays a significant role in the regulation of developmental processes. Its expression is typically downregulated in adult tissues but can be aberrantly reactivated in a variety of cancers, including those of the breast, lung, and hematopoietic system. ROR1 is involved in regulating cell survival, proliferation, and migration, acting through several signaling pathways that are pivotal for both normal developmental processes and the progression of malignancies. The protein's role in cancer is particularly noteworthy, as its activation has been associated with enhanced tumor aggressiveness, metastatic potential, and resistance to therapy. The ability of ROR1 to influence key cellular processes underscores its importance as a mediator of developmental signaling and its reemergence in cancer biology.
The activation of ROR1 involves its interaction with ligands or signaling partners that trigger its tyrosine kinase activity, leading to the initiation of downstream signaling cascades. One proposed mechanism of ROR1 activation is through Wnt5a binding, which can promote ROR1 dimerization and autophosphorylation, activating pathways such as the non-canonical Wnt pathway, PI3K/AKT, and MAPK/ERK, which are crucial for cell migration, survival, and proliferation. This interaction with Wnt5a highlights a critical aspect of ROR1's function, bridging developmental signaling with pathological processes in cancer. Additionally, the activation of ROR1 can lead to the modulation of the tumor microenvironment, promoting a supportive niche for cancer cell growth and metastasis.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
An inhibitor of GSK3β, which is a negative regulator of Wnt signaling. Activation of Wnt can influence ROR1 activity. | ||||||
GSK-3 Inhibitor IX | 667463-62-9 | sc-202634 sc-202634A sc-202634B | 1 mg 10 mg 50 mg | $58.00 $188.00 $884.00 | 10 | |
A GSK3 inhibitor, potentially enhancing the Wnt signaling, thereby influencing ROR1 function. | ||||||
SB-216763 | 280744-09-4 | sc-200646 sc-200646A | 1 mg 5 mg | $71.00 $202.00 | 18 | |
Another GSK3 inhibitor, potentially upregulating Wnt signaling, thereby influencing ROR1 function. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
By increasing cAMP levels, it can influence various signaling pathways, which in turn can affect ROR1 activity. | ||||||
Ionomycin, free acid | 56092-81-0 | sc-263405 sc-263405A | 1 mg 5 mg | $96.00 $264.00 | 2 | |
Raises intracellular calcium concentration, influencing multiple cellular processes that can be associated with ROR1. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
An inhibitor of the MAP kinase pathway, modulating this pathway can influence ROR1-associated processes. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A PI3K inhibitor. Since PI3K/Akt is a downstream effector of many RTKs including ROR1, modulating it can affect ROR1 function. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
An mTOR inhibitor. By influencing mTOR pathway, it can affect downstream effects related to ROR1. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Activates protein kinase C, potentially influencing signaling pathways related to ROR1. | ||||||